In several Phase III clinical trials (such as the SURPASS series), Tirzepatide was signicantly superior to Semaglutide and insulin in reducing glycated hemoglobin (HbA1c) and body weight
L.RodriguesC
Janine A, Kim MM, Sandra E, Karin W, Ingrid S, Julian GM, et al
Membranes were blocked with 5% BSA in TBS0.01% Tween 20 and probed with specific antibodies against PGC-1 (ab176328) and GCL-c (ab53179) purchased from Abcam
The statistical analysis was carried out by GraphPad Prism 8 (San Diego, CA, USA) using an unpaired t-test or two-way analysis of variance (ANOVA) with Bonferronis post-test
Retatrutides 24.2% weight loss compares to the 25-30% typically seen with gastric sleeve surgery, offering similar results without surgical risks or anatomical changes